Innovative drug development platformInnovative drug development platform text description innovative drug development platform textDescribe the innovative drug development platform, text description,
Ginsenoside CK ProjectGinsenoside CK is a metabolite of protopanaxadiol saponin in the human intestinal tract. Based on the cooperation with the research and development team of the Chinese Academy of
Shanghai Hongguan Pharmaceutical Technology Co., Ltd. has advanced equipment, extensive and diversified product lines to help prevent disease and improve health in all stages of life. The powerful pro
Shanghai Hongguan Pharmaceutical Technology Co., Ltd. is a high-tech company with the development, registration and marketing of generic drugs jointly established by Hongguan Bio-Pharmaceutical Co., Ltd. and Shanghai Yusheng Pharmaceutical Technology Co., Ltd.
The company utilizes its experience and advantages in the development, registration and marketing of generic drugs and innovative drugs to provide technical consultation, technical support and technical services for generic drug and innovative drug development and market development for domestic GMP-qualified pharmaceutical companies. And is committed to the promotion of generic drugs in the domestic market.
View details
According to the statistics of Shijiazhuang Customs, from January to September this year, the total import and export value of Hebei Province along the “Belt and Road” was 77.43 billion yuan (the same
2018-11-20Medical Network November 20th Breaking the "foreign monopoly", medical equipment innovation in Hubei Province began to exert its strength. On November 16, the Food and Drug Administration of
2018-11-20On November 14, the Zhejiang Pharmaceutical Machinery Purchasing Center issued a notice requesting bidders to complete the reporting of the lowest online transaction price of the relevant products by
2018-11-20